Nutritional management of gastroenterocutaneous fistulas

Albert Chi, Michael Ditillo

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Despite significant improvements in medical and surgical treatments of gastroenterocutaneous fistulas (ECFs), they remain a significant cause of morbidity and mortality for patients who develop them. A hypermetabolic response and profound disturbances in fluid and electrolyte levels, leading to dehydration, hyponatraemia, hypokalemia, and metabolic acidosis, are common, making this patient population a unique subgroup of critically ill patients vulnerable to further decline in nutritional status. In general, medical treatment and stabilization precede attempts at surgical intervention and remain a hallmark of therapy for ECFs. The most challenging aspect of ECF management is nutritional repletion because there is no standard protocol, and each patient and case is unique. The management requires patient- as well as fistula-specific factors to be considered for optimizing the best treatment regimen. Currently, there are no well-established, evidence-based clinical guidelines for managing the medications and nutrition care of these patients. Although it is often difficult and sometimes impossible to provide adequate enteral nutrition in the presences of an ECF, nutritional support should be implemented whenever possible. Many questions have been answered; however, there is no uniformity to these answers. This chapter reviews the roles of enteral and supplemental parenteral nutrition, somatostatin, and immune-modulating nutritional supplementation.

Original languageEnglish (US)
Title of host publicationSurgery of Complex Abdominal Wall Defects
PublisherSpringer New York
Pages199-202
Number of pages4
ISBN (Electronic)9781461463542
ISBN (Print)9781461463535
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Fistula
Hypokalemia
Nutritional Support
Hyponatremia
Parenteral Nutrition
Enteral Nutrition
Therapeutics
Acidosis
Somatostatin
Nutritional Status
Dehydration
Critical Illness
Electrolytes
Small Intestine
Patient Care
Guidelines
Morbidity
Mortality
Population

Keywords

  • Enteral nutrition
  • Fistula
  • Gastro-enterocutaneous fistula
  • Glutamine, arginine
  • Malnutrition
  • Micronutrients, trace elements
  • Octreotide
  • Total parenteral nutrition

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chi, A., & Ditillo, M. (2013). Nutritional management of gastroenterocutaneous fistulas. In Surgery of Complex Abdominal Wall Defects (pp. 199-202). Springer New York. https://doi.org/10.1007/978-1-4614-6354-2_23

Nutritional management of gastroenterocutaneous fistulas. / Chi, Albert; Ditillo, Michael.

Surgery of Complex Abdominal Wall Defects. Springer New York, 2013. p. 199-202.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chi, A & Ditillo, M 2013, Nutritional management of gastroenterocutaneous fistulas. in Surgery of Complex Abdominal Wall Defects. Springer New York, pp. 199-202. https://doi.org/10.1007/978-1-4614-6354-2_23
Chi A, Ditillo M. Nutritional management of gastroenterocutaneous fistulas. In Surgery of Complex Abdominal Wall Defects. Springer New York. 2013. p. 199-202 https://doi.org/10.1007/978-1-4614-6354-2_23
Chi, Albert ; Ditillo, Michael. / Nutritional management of gastroenterocutaneous fistulas. Surgery of Complex Abdominal Wall Defects. Springer New York, 2013. pp. 199-202
@inbook{3a1f681dd07a40b4afdbaeecfb8da910,
title = "Nutritional management of gastroenterocutaneous fistulas",
abstract = "Despite significant improvements in medical and surgical treatments of gastroenterocutaneous fistulas (ECFs), they remain a significant cause of morbidity and mortality for patients who develop them. A hypermetabolic response and profound disturbances in fluid and electrolyte levels, leading to dehydration, hyponatraemia, hypokalemia, and metabolic acidosis, are common, making this patient population a unique subgroup of critically ill patients vulnerable to further decline in nutritional status. In general, medical treatment and stabilization precede attempts at surgical intervention and remain a hallmark of therapy for ECFs. The most challenging aspect of ECF management is nutritional repletion because there is no standard protocol, and each patient and case is unique. The management requires patient- as well as fistula-specific factors to be considered for optimizing the best treatment regimen. Currently, there are no well-established, evidence-based clinical guidelines for managing the medications and nutrition care of these patients. Although it is often difficult and sometimes impossible to provide adequate enteral nutrition in the presences of an ECF, nutritional support should be implemented whenever possible. Many questions have been answered; however, there is no uniformity to these answers. This chapter reviews the roles of enteral and supplemental parenteral nutrition, somatostatin, and immune-modulating nutritional supplementation.",
keywords = "Enteral nutrition, Fistula, Gastro-enterocutaneous fistula, Glutamine, arginine, Malnutrition, Micronutrients, trace elements, Octreotide, Total parenteral nutrition",
author = "Albert Chi and Michael Ditillo",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-6354-2_23",
language = "English (US)",
isbn = "9781461463535",
pages = "199--202",
booktitle = "Surgery of Complex Abdominal Wall Defects",
publisher = "Springer New York",

}

TY - CHAP

T1 - Nutritional management of gastroenterocutaneous fistulas

AU - Chi, Albert

AU - Ditillo, Michael

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Despite significant improvements in medical and surgical treatments of gastroenterocutaneous fistulas (ECFs), they remain a significant cause of morbidity and mortality for patients who develop them. A hypermetabolic response and profound disturbances in fluid and electrolyte levels, leading to dehydration, hyponatraemia, hypokalemia, and metabolic acidosis, are common, making this patient population a unique subgroup of critically ill patients vulnerable to further decline in nutritional status. In general, medical treatment and stabilization precede attempts at surgical intervention and remain a hallmark of therapy for ECFs. The most challenging aspect of ECF management is nutritional repletion because there is no standard protocol, and each patient and case is unique. The management requires patient- as well as fistula-specific factors to be considered for optimizing the best treatment regimen. Currently, there are no well-established, evidence-based clinical guidelines for managing the medications and nutrition care of these patients. Although it is often difficult and sometimes impossible to provide adequate enteral nutrition in the presences of an ECF, nutritional support should be implemented whenever possible. Many questions have been answered; however, there is no uniformity to these answers. This chapter reviews the roles of enteral and supplemental parenteral nutrition, somatostatin, and immune-modulating nutritional supplementation.

AB - Despite significant improvements in medical and surgical treatments of gastroenterocutaneous fistulas (ECFs), they remain a significant cause of morbidity and mortality for patients who develop them. A hypermetabolic response and profound disturbances in fluid and electrolyte levels, leading to dehydration, hyponatraemia, hypokalemia, and metabolic acidosis, are common, making this patient population a unique subgroup of critically ill patients vulnerable to further decline in nutritional status. In general, medical treatment and stabilization precede attempts at surgical intervention and remain a hallmark of therapy for ECFs. The most challenging aspect of ECF management is nutritional repletion because there is no standard protocol, and each patient and case is unique. The management requires patient- as well as fistula-specific factors to be considered for optimizing the best treatment regimen. Currently, there are no well-established, evidence-based clinical guidelines for managing the medications and nutrition care of these patients. Although it is often difficult and sometimes impossible to provide adequate enteral nutrition in the presences of an ECF, nutritional support should be implemented whenever possible. Many questions have been answered; however, there is no uniformity to these answers. This chapter reviews the roles of enteral and supplemental parenteral nutrition, somatostatin, and immune-modulating nutritional supplementation.

KW - Enteral nutrition

KW - Fistula

KW - Gastro-enterocutaneous fistula

KW - Glutamine, arginine

KW - Malnutrition

KW - Micronutrients, trace elements

KW - Octreotide

KW - Total parenteral nutrition

UR - http://www.scopus.com/inward/record.url?scp=84961359906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961359906&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-6354-2_23

DO - 10.1007/978-1-4614-6354-2_23

M3 - Chapter

AN - SCOPUS:84961359906

SN - 9781461463535

SP - 199

EP - 202

BT - Surgery of Complex Abdominal Wall Defects

PB - Springer New York

ER -